POSTmark™ LVV

Our Platform Optimized for Scale-up and Transfer (POSTmark) is equipped with mirrored R&D and cGMP equipment and processes, providing comprehensive support across all stages of development from initial research to full cGMP scale-up. Designed to streamline lentiviral vector (LVV) production, POSTmark enables cGMP-grade LVV manufacturing in just 6–9 months, while ensuring that research-grade LVV accurately represents cGMP standards. This mirrored approach minimizes time, costs, and risks, offering a reliable, efficient path from R&D to scalable production.